Home > Financial Ratios > INDOCO REMEDIES

INDOCO REMEDIES
Core EBITDA Growth

    Back to All Ratios
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -58.96-11.62-12.4444.9880.98

What is the latest Core EBITDA Growth ratio of INDOCO REMEDIES ?

The latest Core EBITDA Growth ratio of INDOCO REMEDIES is -58.96 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-58.96
Mar2024-11.62
Mar2023-12.44
Mar202244.98
Mar202180.98

How is Core EBITDA Growth of INDOCO REMEDIES Trending?

Years Core EBITDA Growth % Change
Mar2025 -58.96
Negative
Mar2024 -11.62
Negative
Mar2023 -12.44
Negative
Mar2022 44.98
-44.46
Mar2021 80.98 -

Other Financial Ratios of INDOCO REMEDIES


Compare Core EBITDA Growth ratio of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,583.4 Cr -0.8% -3.5% -9.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,751.0 Cr 0.2% 7.1% -7.7% Stock Analytics
DIVIS LABORATORIES ₹176,634.0 Cr 1% 16.8% 12.7% Stock Analytics
CIPLA ₹124,437.0 Cr -2.7% 3.5% 6.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,871.0 Cr 0.6% 0.4% 4.7% Stock Analytics
DR REDDYS LABORATORIES ₹100,333.0 Cr -6.4% -2.7% -3.9% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-0.8%

-3.5%

-9.2%

SENSEX

-0.2%

5%

5.4%


You may also like the below Video Courses